Skip to main content
Top

International Journal of Clinical Oncology

Issue 4/2017

Content (27 Articles)

Invited Review Article

Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance

Katsutoshi Oda, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori-Uchino, Yutaka Osuga, Tomoyuki Fujii

Open Access Review Article

Biomarkers to predict prognosis and response to checkpoint inhibitors

Takeshi Yuasa, Hitoshi Masuda, Shinya Yamamoto, Noboru Numao, Junji Yonese

Review Article

Biphasic malignant tumours of the abdominal cavity

L. Max Almond, Adrian T. Warfield, Anant Desai, David Gourevitch, Samuel J. Ford

Review Article

Brachytherapy in the treatment of breast cancer

Xinna Deng, Haijiang Wu, Fei Gao, Ye Su, Qingxia Li, Shuzhen Liu, Jianhui Cai

Review Article

Targeting metabolic reprogramming in KRAS-driven cancers

Kenji Kawada, Kosuke Toda, Yoshiharu Sakai

Original Article

Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas

Zheng Cai, Chenran Zhang, Yongxiang Zou, Chengyin Lu, Hongkang Hu, Jun Qian, Lei Jiang, Guohan Hu

Original Article

Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan

Takatsugu Mizumachi, Akihiro Homma, Tomohiro Sakashita, Satoshi Kano, Hiromitsu Hatakeyama, Satoshi Fukuda

Original Article

Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer

Haruki Kobayashi, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, Toshiaki Takahashi

Original Article

A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors

Hiromitsu Iwata, Satoshi Ishikura, Taro Murai, Michio Iwabuchi, Mitsuhiro Inoue, Koshi Tatewaki, Seiji Ohta, Naoki Yokota, Yuta Shibamoto

Original Article

Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection

Tsuyoshi Notake, Akira Kobayashi, Hiroji Shinkawa, Takuya Kawahara, Akira Shimizu, Takahide Yokoyama, Kiyoshi Hasegawa, Norihiro Kokudo, Yutaka Matsuyama, Masatoshi Makuuchi, Shin-ichi Miyagawa

Original Article

Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors

Kota Arima, Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Hidetoshi Nitta, Takaaki Higashi, Takayoshi Kaida, Kensuke Yamamura, Yuki Kitano, Yoshihiro Komohara, Yo-ichi Yamashita, Toru Beppu, Motohiro Takeya, Hideo Baba

Original Article

Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection

Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Daisuke Izumi, Keisuke Kosumi, Katsunobu Taki, Takaaki Higashi, Tatsunori Miyata, Yuji Miyamoto, Naoya Yoshida, Hideo Baba

Original Article

The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis

Ding Ye, Danjie Jiang, Yingjun Li, Mingjuan Jin, Kun Chen

Original Article

Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases

Tadanobu Shimura, Yuji Toiyama, Susumu Saigusa, Hiroki Imaoka, Masato Okigami, Hiroyuki Fujikawa, Junichiro Hiro, Minako Kobayashi, Masaki Ohi, Toshimitsu Araki, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri, Masato Kusunoki

Original Article

Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma

Hironori Fukuda, Tsunenori Kondo, Toshio Takagi, Jumpei Iizuka, Yoji Nagashima, Kazunari Tanabe

Original Article

Dominant lymph drainage patterns in the occipital and parietal regions: evaluation of lymph nodes in patients with skin cancer of the head

Taku Maeda, Yuhei Yamamoto, Hiroshi Furukawa, Akihiko Oyama, Emi Funayama, Naoki Murao, Toshihiko Hayashi

Open Access Original Article

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

Akihiko Shimomura, Shunsuke Kondo, Noriko Kobayashi, Satoru Iwasa, Shigehisa Kitano, Kenji Tamura, Yutaka Fujiwara, Noboru Yamamoto

Open Access Original Article

Patient perceptions of symptoms and concerns during cancer chemotherapy: ‘affects my family’ is the most important

H. Sasaki, K. Tamura, Y. Naito, K. Ogata, A. Mogi, T. Tanaka, Y. Ikari, M. Masaki, Y. Nakashima, Y. Takamatsu

Erratum

Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

Takeshi Suto, Megumi Ishiguro, Chikuma Hamada, Katsuyuki Kunieda, Hiroyuki Masuko, Ken Kondo, Hideyuki Ishida, Genichi Nishimura, Kazuaki Sasaki, Takayuki Morita, Shoichi Hazama, Koutarou Maeda, Hideyuki Mishima, Hideyuki Ike, Sotaro Sadahiro, Kenichi Sugihara, Masazumi Okajima, Shigetoyo Saji, Junichi Sakamoto, Naohiro Tomita

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine